Featured Article
A team of researchers from around the world have discovered more than 100 new regions in the human genome that seem to influence a person’s blood pressure.
Precision Oncology Today
Magazine
Beginning a New Era of Precision Alzheimer’s Therapeutics
Alzheimer’s is a disease associated with aging and impacts almost seven million people in the U.S. over the age of 65, with women and Black or Hispanic populations disproportionately affected by the condition. Finding an effective treatment for Alzheimer’s disease has proved to be a long and difficult quest.
5 Startups With Proteomics Potential Attracting Investor Cash
Investor appetite is growing for startups that can make proteomics faster, cheaper, and more informative for use in precision medicine. Here are five proteomics...
Trending on Inside Precision Medicine
Quebec Project to Tackle Diabetic Kidney Disease
An industry-academia project in Quebec will establish a biobank and carry out research to better diagnose and treat diabetic kidney disease.
Over 100 New Regions Linked to Blood Pressure in the Human Genome
A team of researchers from around the world have discovered more than 100 new regions in the human genome that seem to influence a person’s blood pressure.
Enlaza Nets $100M to Advance Covalent Biologics Platform
Enlaza Therapeutics announced a $100 million Series A financing with the aim is to bring covalency to biologic therapies. This approach could be useful in one of today’s most active areas of cancer drug development.
